BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 21034162)

  • 21. Epistatic effect of plasminogen activator inhibitor 1 and beta-fibrinogen genes on risk of glomerular microthrombosis in lupus nephritis: interaction with environmental/clinical factors.
    Gong R; Liu Z; Li L
    Arthritis Rheum; 2007 May; 56(5):1608-17. PubMed ID: 17469143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diabetic retinopathy, PAI-1 4G/5G and -844G/A polymorphisms, and changes in circulating PAI-1 levels in Tunisian type 2 diabetes patients.
    Ezzidi I; Mtiraoui N; Chaieb M; Kacem M; Mahjoub T; Almawi WY
    Diabetes Metab; 2009 Jun; 35(3):214-9. PubMed ID: 19419896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The influence of I/D polymorphism of the angiotensin I converting enzyme (ACE) gene and 4G/5G polymorphism of plasminogen activator inhibitor (PAI-1) gene promoter on the haemostatic system in patients with essential hypertension and dyslipidemia].
    Nowakowska A
    Ann Acad Med Stetin; 2005; 51(1):95-105. PubMed ID: 16496609
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of platelet membrane glycoprotein polymorphisms on the risk of myocardial infarction in young males.
    Rosenberg N; Zivelin A; Chetrit A; Dardik R; Kornbrot N; Freimark D; Inbal A
    Isr Med Assoc J; 2002 Jun; 4(6):411-4. PubMed ID: 12073410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Relationship between polymorphisms of plasminogen activator inhibitor-1 promoter gene and pulmonary thromboembolism in Chinese Han population].
    Zhai ZG; Wang C; Yang YH; Pang BS; Xiao B; Liu YM; Mao YL; Weng XZ
    Zhonghua Yi Xue Za Zhi; 2006 May; 86(19):1313-7. PubMed ID: 16796899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Genetic variations in plasminogen activator inhibitor-1 gene and beta fibrinogen gene associated with glomerular microthrombosis in lupus nephritis and the gene dosage effect].
    Gong R; Liu Z; Chen Z; Li L
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Feb; 19(1):1-5. PubMed ID: 11836675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic risk factors in myocardial infarction at young age.
    Incalcaterra E; Hoffmann E; Averna MR; Caimi G
    Minerva Cardioangiol; 2004 Aug; 52(4):287-312. PubMed ID: 15284679
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene is associated with severe preeclampsia.
    Yamada N; Arinami T; Yamakawa-Kobayashi K; Watanabe H; Sohda S; Hamada H; Kubo T; Hamaguchi H
    J Hum Genet; 2000; 45(3):138-41. PubMed ID: 10807538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spectrum and prevalence of prothrombotic single nucleotide polymorphism profiles in the Greek Cypriot population.
    Xenophontos SL; Hadjivassiliou M; Ayrton N; Karagrigoriou A; Pantzaris M; Nicolaides AN; Cariolou MA
    Int Angiol; 2002 Dec; 21(4):322-9. PubMed ID: 12518110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasminogen activator inhibitor-1 4G/5G polymorphism in breast cancer patients and its association with tissue PAI-1 levels and tumor severity.
    Castelló R; España F; Vázquez C; Fuster C; Almenar SM; Aznar J; Estellés A
    Thromb Res; 2006; 117(5):487-92. PubMed ID: 15907980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene polymorphisms implicated in influencing susceptibility to venous and arterial thromboembolism: frequency distribution in a healthy German population.
    Hoppe B; Tolou F; Dörner T; Kiesewetter H; Salama A
    Thromb Haemost; 2006 Oct; 96(4):465-70. PubMed ID: 17003923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasminogen activator inhibitor 1 (PAI-1) levels and gene promoter polymorphisms in subjects with colorectal cancer.
    Smolarz B; Blasiak J; Kulig A; Romanowicz-Makowska H; Dziki A; Ulanska J; Pander B; Szewczyk T
    J Exp Clin Cancer Res; 2001 Jun; 20(2):247-52. PubMed ID: 11484982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of association between gene sequence variations of platelet membrane receptors and aspirin responsiveness detected by the PFA-100 system in patients with coronary artery disease.
    Bernardo E; Angiolillo DJ; Ramírez C; Cavallari U; Trabetti E; Sabaté M; Hernández R; Moreno R; Escaned J; Alfonso F; Bañuelos C; Costa MA; Bass TA; Pignatti PF; Macaya C; Fernandez-Ortiz A
    Platelets; 2006 Dec; 17(8):586-90. PubMed ID: 17127487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of association between IL-1 and IL-6 gene polymorphisms and myocardial infarction in Turkish population.
    Coker A; Arman A; Soylu O; Tezel T; Yildirim A
    Int J Immunogenet; 2011 Jun; 38(3):201-8. PubMed ID: 21199393
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of the fibrinogen beta-chain, angiotensin-converting enzyme and plasminogen activator inhibitor-1 polymorphisms in Costa Rican young adults with thrombotic disease.
    Hidalgo A; Salazar-Sanchez L; Cartin M; Mendez M; Arauz J; Parajeles A
    Cell Biochem Funct; 2010 Jul; 28(5):367-73. PubMed ID: 20535834
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between gene polymorphism of the PAI-1 promoter and myocardial infarction.
    Fu L; Jin H; Song K; Zhang C; Shen J; Huang Y
    Chin Med J (Engl); 2001 Mar; 114(3):266-9. PubMed ID: 11780311
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of the gene polymorphisms of platelet glycoprotein Ia and IIb/IIIa with myocardial infarction and extent of coronary artery disease in the Korean population.
    Park S; Park HY; Park C; Ko YG; Im EK; Jo I; Shin C; Lee JB; Shim WH; Cho SY; Jang Y
    Yonsei Med J; 2004 Jun; 45(3):428-34. PubMed ID: 15227729
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of COX-2 rs5275 and rs20417 and GPIIIa rs5918 polymorphisms on 90-day ischemic stroke functional outcome: a novel finding.
    Maguire J; Thakkinstian A; Levi C; Lincz L; Bisset L; Sturm J; Scott R; Whyte S; Attia J
    J Stroke Cerebrovasc Dis; 2011; 20(2):134-44. PubMed ID: 20472470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The 4G/5G sequence polymorphism in the promoter of plasminogen activator inhibitor-1 (PAI-1) gene: relationship to plasma PAI-1 level in venous thromboembolism.
    Stegnar M; Uhrin P; Peternel P; Mavri A; Salobir-Pajnic B; Stare J; Binder BR
    Thromb Haemost; 1998 May; 79(5):975-9. PubMed ID: 9609232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism, coronary thrombosis, and myocardial infarction in middle-aged Finnish men who died suddenly.
    Mikkelsson J; Perola M; Wartiovaara U; Peltonen L; Palotie A; Penttilä A; Karhunen PJ
    Thromb Haemost; 2000 Jul; 84(1):78-82. PubMed ID: 10928474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.